These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 36120471)

  • 1. Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis.
    Mao L; Yin R; Yang L; Zhao D
    Front Endocrinol (Lausanne); 2022; 13():983723. PubMed ID: 36120471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State.
    Bao Z; Li L; Geng Y; Yan J; Dai Z; Shao C; Sun Z; Jing L; Pang Q; Zhang L; Wang X; Wang Z
    Mediators Inflamm; 2020; 2020():6850187. PubMed ID: 32831637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
    Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
    BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis.
    Singh S; Siva BV; Ravichandiran V
    Glycoconj J; 2022 Aug; 39(4):547-563. PubMed ID: 35579827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
    Basta G; Schmidt AM; De Caterina R
    Cardiovasc Res; 2004 Sep; 63(4):582-92. PubMed ID: 15306213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle cell pathophysiology and advanced glycation end products (AGEs).
    Yamagishi S; Matsui T
    Curr Drug Targets; 2010 Jul; 11(7):875-81. PubMed ID: 20412043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation.
    Li Y; Liu S; Zhang Z; Xu Q; Xie F; Wang J; Ping S; Li C; Wang Z; Zhang M; Huang J; Chen D; Hu L; Li C
    PLoS One; 2012; 7(4):e35016. PubMed ID: 22496883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus.
    Katakami N
    J Atheroscler Thromb; 2018 Jan; 25(1):27-39. PubMed ID: 28966336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D Attenuates the Proliferation of Vascular Smooth Muscle Cells Induced by the AGE/RAGE Pathway by Suppressing the ERK Signal.
    Ye N; Miao L; Wang F; Wu S; Wu B; Zhou Y; Wang C; Sun G
    Curr Pharm Des; 2023; 29(30):2387-2395. PubMed ID: 37855363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis.
    Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G
    Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth muscle NF90 deficiency ameliorates diabetic atherosclerotic calcification in male mice via FBXW7-AGER1-AGEs axis.
    Xie F; Liu B; Qiao W; He JZ; Cheng J; Wang ZY; Hou YM; Zhang X; Xu BH; Zhang Y; Chen YG; Zhang MX
    Nat Commun; 2024 Jun; 15(1):4985. PubMed ID: 38862515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells.
    Hu P; Lai D; Lu P; Gao J; He H
    Int J Mol Med; 2012 Apr; 29(4):613-8. PubMed ID: 22293957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
    Khalid M; Petroianu G; Adem A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.
    Fishman SL; Sonmez H; Basman C; Singh V; Poretsky L
    Mol Med; 2018 Nov; 24(1):59. PubMed ID: 30470170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.
    Nam MH; Son WR; Lee YS; Lee KW
    Cell Commun Adhes; 2015; 22(2-6):67-78. PubMed ID: 27602595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function.
    Matsumoto T; Taguchi K; Kobayashi T
    J Smooth Muscle Res; 2021; 57(0):94-107. PubMed ID: 35095032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.